PAREXEL Strengthens Leading Presence in Latin America With a New Locati...(ffairs biostatistics and bioanalysis for...),Health

Date:11/20/2008

ffairs, biostatistics, and bioanalysis for the conduct of Phase II-IV studies. PAREXEL's clinical logistics team in Latin America, with in-depth expertise in import and export regulations, coordinates multinational logistics and helps clients effectively manage global clinical trial supply requirements. PAREXEL's Latin American locations offer extensive late phase development capabilities including observational studies, patient registries, outcomes research, and expanded access programs.

For more information about PAREXEL's global Clinical Research Services, visit http://www.parexel.com/clinical_research.html.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world, and has over 9,180 employees. For more information about PAREXEL International visit www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events. For this purpose, any statements contained herein that ar
'/>"/>

SOURCE PAREXEL International Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
2. PAREXEL Expands Global Clinical Pharmacology Capabilities
3. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
4. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
7. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
8. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
9. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
10. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
11. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates